These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30540616)

  • 1. Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members.
    Sniecinski RM; Bennett-Guerrero E; Shore-Lesserson L
    Anesth Analg; 2019 Aug; 129(2):e41-e44. PubMed ID: 30540616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey of Practice Pattern in Patients With Heparin-Induced Thrombocytopenia Requiring Cardiopulmonary Bypass.
    Wanat-Hawthorne A; Tanaka K; Angona R; Feng C; Eaton M
    Anesth Analg; 2021 Nov; 133(5):1180-1186. PubMed ID: 34415867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass.
    Shore-Lesserson L; Baker RA; Ferraris VA; Greilich PE; Fitzgerald D; Roman P; Hammon JW
    Anesth Analg; 2018 Feb; 126(2):413-424. PubMed ID: 29346209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated clotting time during cardiopulmonary bypass: is repetition necessary during open heart surgery?
    Neema PK; Sinha PK; Rathod RC
    Asian Cardiovasc Thorac Ann; 2004 Mar; 12(1):47-52. PubMed ID: 14977742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of heparin resistance due to acquired antithrombin III deficiency.
    Leong CK; Ong BC
    Ann Acad Med Singap; 1998 Nov; 27(6):877-9. PubMed ID: 10101569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the activated clotting time in anticoagulation monitoring of intravascular procedures.
    Bowers J; Ferguson JJ
    Tex Heart Inst J; 1993; 20(4):258-63. PubMed ID: 8298321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass.
    Nicholson SC; Keeling DM; Sinclair ME; Evans RD
    Br J Anaesth; 2001 Dec; 87(6):844-7. PubMed ID: 11878684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
    Heller EL; Paul L
    J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass.
    Shore-Lesserson L; Baker RA; Ferraris VA; Greilich PE; Fitzgerald D; Roman P; Hammon JW
    Ann Thorac Surg; 2018 Feb; 105(2):650-662. PubMed ID: 29362176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
    Bauer A; Hausmann H; Schaarschmidt J; Szlapka M; Scharpenberg M; Eberle T; Hasenkam JM
    Thorac Cardiovasc Surg; 2019 Apr; 67(3):191-202. PubMed ID: 29290078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin concentrations in neonates during cardiopulmonary bypass.
    Davidson SJ; Tillyer ML; Keogh J; Hall J; Kelleher AA
    J Thromb Haemost; 2012 Apr; 10(4):730-2. PubMed ID: 22329742
    [No Abstract]   [Full Text] [Related]  

  • 14. Supplemental Antithrombin Is Effective in Achieving Adequate Anticoagulation in Infants and Children With an Inadequate Response to Heparin.
    Lopez M; Feng C; Vasilyeva O; Eaton MP
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):896-900. PubMed ID: 28242144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation management associated with extracorporeal circulation.
    Sniecinski RM; Levy JH
    Best Pract Res Clin Anaesthesiol; 2015 Jun; 29(2):189-202. PubMed ID: 26060030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEG improves anticoagulation management during cardiopulmonary bypass complicated by antiphospholipid syndrome.
    Nakajima T; Kato H; Mathis BJ; Hiramatsu Y; Sakamoto H
    J Card Surg; 2020 Jun; 35(6):1354-1356. PubMed ID: 32302025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparin resistance during cardiopulmonary bypass].
    Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
    Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of real-world heparin resistance and anticoagulation management prior to cardiopulmonary bypass: report from a nationwide survey by the Japanese Association for Thoracic Surgery heparin resistance working group.
    Ito K; Sasaki K; Ono M; Suzuki T; Sakamoto K; Okamoto H; Katori N; Momose N; Araki Y; Tojo K; Ieko M; Komiyama Y; Saiki Y
    Gen Thorac Cardiovasc Surg; 2024 Jan; 72(1):8-14. PubMed ID: 37195584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.